Recent advances of exosomes in immune modulation and autoimmune diseases

Autoimmunity

Volumn 49, Issue 6, 2016, Pages 357-365

  Tan, Lina ^a,b   Wu, Haijing ^b   Liu, Ying ^b   Zhao, Ming ^b   Li, Duo ^b   Lu, Qianjin ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Exosome; microRNA; rheumatoid arthritis; Sjogren s syndrome; systemic lupus erythematosus

Indexed keywords

MESSENGER RNA; MICRORNA; UNTRANSLATED RNA; BIOLOGICAL MARKER;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMMUNICATION; DENDRITIC CELL; EXOSOME; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; ANIMAL; AUTOIMMUNITY; CYTOLOGY; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BIOLOGICAL TRANSPORT; BIOMARKERS; EXOSOMES; HUMANS; IMMUNE SYSTEM; IMMUNOMODULATION; MICRORNAS; MOLECULAR TARGETED THERAPY;

EID: 84976328958     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916934.2016.1191477     Document Type: Review

References (102)

1. Ajit, S. K., 2012. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors. 12:3359–3369
2. Natasha, G., B., Gundogan, A., Tan, et al. 2014. Exosomes as immunotheranostic nanoparticles. Clin. Ther. 36:820–829
3. Rekker, K., M., Saare, A. M., Roost, et al. 2014. Comparison of serum exosome isolation methods for microRNA profiling. Clin. Biochem. 47:135–138
4. Stoorvogel, W., M. J., Kleijmeer, H. J., Geuze, et al. 2002. The biogenesis and functions of exosomes. Traffic. 3:321–330
5. Zhang, L., and J. L., Wrana. 2014. The emerging role of exosomes in Wnt secretion and transport. Curr. Opin. Genetics. Dev. 27:14–19
6. Keller, S., J., Ridinger, A. K., Rupp, et al. 2011. Body fluid derived exosomes as a novel template for clinical diagnostics. J. Transl. Med. 9:86–94
7. Raposo, G., H. W., Nijman, W., Stoorvogel, et al. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1161–1172
8. Agarwal, A., G., Fanelli, M., Letizia, et al. 2014. Regulatory T cell-derived exosomes:possible therapeutic and diagnostic tools in transplantation. Front. Immunol. 5:555–561
9. Zhang, B., Y., Yin, R. C., Lai, et al. 2014. Immunotherapeutic potential of extracellular vesicles. Front. Immunol. 5:518
10. Chaput, N., J., Taieb, N. E., Schartz, et al. 2004. Exosome-based immunotherapy. Cancer Immunol. Immunother. CII. 53:234–239
11. Beach, A., H. G., Zhang, M. Z., Ratajczak, et al. 2014. Exosomes:an overview of biogenesis, composition and role in ovarian cancer. J. Ovarian. Res. 7:14–24
12. Buschow, S. I., B. W., van Balkom, M., Aalberts, et al. 2010. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol. Cell. Biol. 88:851–856
13. Gehrmann, U., T. I., Naslund, S., Hiltbrunner, et al. 2014. Harnessing the exosome-induced immune response for cancer immunotherapy. Semin. Cancer Biol. 28:58–67
14. Viaud, S., C., Thery, S., Ploix, et al. 2010. Dendritic cell-derived exosomes for cancer immunotherapy:what's next? Cancer Res. 70:1281–1285
15. Thery, C., L., Duban, E., Segura, et al. 2002. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat. Immunol. 3:1156–1162
16. Buschow, S. I., E. N., Nolte-'t Hoen, G., van Niel, et al. 2009. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic. 10:1528–1542
17. Segura, E., C., Nicco, B., Lombard, et al. 2005. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood. 106:216–223
18. Quah, B. J., and H. C., O'Neill. 2005. The immunogenicity of dendritic cell-derived exosomes. Blood Cells Mol Dis. 35:94–110
19. Pant, S., H., Hilton, and M. E., Burczynski. 2012. The multifaceted exosome:biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem. Pharmacol. 83:1484–1494
20. Andre, F., N., Chaput, N. E., Schartz, et al. 2004. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 172:2126–2136
21. Thery, C., A., Regnault, J., Garin, et al. 1999. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell. Biol. 147:599–610
22. Hwang, I., 2013. Cell-cell communication via extracellular membrane vesicles and its role in the immune response. Mol. Cells. 36:105–111
23. Knight, A. M., 2008. Regulated release of B cell-derived exosomes:do differences in exosome release provide insight into different APC function for B cells and DC? Eur. J. Immunol. 38:1186–1189
24. Garside, P., E., Ingulli, R. R., Merica, et al. 1998. Visualization of specific B and T lymphocyte interactions in the lymph node. Science. 281:96–99
25. Yan, J., B. P., Harvey, R. J., Gee, et al. 2006. B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation. J. Immunol. 177:4481–4487
26. Frydrychowicz, M., A., Kolecka-Bednarczyk, M., Madejczyk, et al. 2015. Exosomes - structure, biogenesis and biological role in non-small-cell lung cancer. Scand. J. Immunol. 81:2–10
27. Clayton, A., A., Turkes, S., Dewitt, et al. 2004. Adhesion and signaling by B cell-derived exosomes:the role of integrins. FASEB J. 18:977–979
28. Ren, Y., J., Yang, R., Xie, et al. 2011. Exosomal-like vesicles with immune-modulatory features are present in human plasma and can induce CD4+ T-cell apoptosis in vitro. Transfusion. 51:1002–1011
29. Papp, K., P., Vegh, J., Prechl, et al. 2008. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity. Mol. Immunol. 45:2343–2351
30. Klinker, M. W., V., Lizzio, T. J., Reed, et al. 2014. Human B cell-derived lymphoblastoid cell lines constitutively produce Fas ligand and secrete MHCII(+)FasL(+) killer exosomes. Front. Immunol. 5:144–153
31. O'Neill, H. C., and B. J., Quah. 2008. Exosomes secreted by bacterially infected macrophages are proinflammatory. Science Signal. 1:pe8
32. Schorey, J. S., and S., Bhatnagar. 2008. Exosome function:from tumor immunology to pathogen biology. Traffic. 9:871–881
33. Bhatnagar, S., and J. S., Schorey. 2007. Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory. J. Biol. Chem. 282:25779–25789
34. Hassani, K., and M., Olivier. 2013. Immunomodulatory impact of leishmania-induced macrophage exosomes:a comparative proteomic and functional analysis. PLoS. Negl. Trop. Dis. 7:e2185
35. McDonald, M. K., Y., Tian, R. A., Qureshi, et al. 2014. Functional significance of macrophage-derived exosomes in inflammation and pain. Pain. 155:1527–1539
36. Smyth, L. A., K., Ratnasothy, J. Y., Tsang, et al. 2013. CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function. Eur. J. Immunol. 43:2430–2440
37. Okoye, I. S., S. M., Coomes, V. S., Pelly, et al. 2014. MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity. 41:89–103
38. Chatila, T. A., and C. B., Williams. 2014. Regulatory T cells:exosomes deliver tolerance. Immunity. 41:3–5
39. Xie, Y., X., Zhang, T., Zhao, et al. 2013. Natural CD8(+)25(+) regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanoma. Biochem. Biophys. Res. Commun. 438:152–155
40. Villarroya-Beltri, C., C., Gutierrez-Vazquez, F., Sanchez-Cabo, et al. 2013. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4:2980–2989
41. Xiao, C., and K., Rajewsky. 2009. MicroRNA control in the immune system:basic principles. Cell. 136:26–36
42. Bronevetsky, Y., and K. M., Ansel. 2013. Regulation of miRNA biogenesis and turnover in the immune system. Immunol. Rev. 253:304–316
43. Montecalvo, A., A. T., Larregina, W. J., Shufesky, et al. 2012. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood. 119:756–766
44. Fernandez-Messina, L., C., Gutierrez-Vazquez, E., Rivas-Garcia, et al. 2015. Immunomodulatory role of microRNAs transferred by extracellular vesicles. Biol. Cell. 107:61–77
45. Almanza, G., V., Anufreichik, J. J., Rodvold, et al. 2013. Synthesis and delivery of short, noncoding RNA by B lymphocytes. Proc. Natl. Acad. Sci. USA. 110:20182–20187
46. Momen-Heravi, F., S., Bala, T., Bukong, et al. 2014. Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomed. 10:1517–1527
47. Ismail, N., Y., Wang, D., Dakhlallah, et al. 2013. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood. 121:984–995
48. Yang, M., J., Chen, F., Su, et al. 2011. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer. 10:117–129
49. de Candia, P., A., Torri, M., Pagani, et al. 2014. Serum microRNAs as biomarkers of human lymphocyte activation in health and disease. Front. Immunol. 5:43–48
50. Gutierrez-Vazquez, C., C., Villarroya-Beltri, M., Mittelbrunn, et al. 2013. Transfer of extracellular vesicles during immune cell-cell interactions. Immunol. Rev. 251:125–142
51. Mittelbrunn, M., C., Gutierrez-Vazquez, C., Villarroya-Beltri, et al. 2011. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2:282–291
52. Gibbings, D. J., C., Ciaudo, M., Erhardt, et al. 2009. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nature. Cell. Biol. 11:1143–1149
53. Rana, S., K., Malinowska, and M., Zoller. 2013. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia. 15:281–295
54. Bryniarski, K., W., Ptak, A., Jayakumar, et al. 2013. Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J. Allergy Clin. Immunol. 132:170–181
55. Dreux, M., U., Garaigorta, B., Boyd, et al. 2012. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell. Host. Microbe. 12:558–570
56. Pegtel, D. M., K., Cosmopoulos, D. A., Thorley-Lawson, et al. 2010. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. USA. 107:6328–6333
57. Cereghetti, D. M., and P. P., Lee. 2014. Tumor-derived exosomes contain microRNAs with immunological function:implications for a novel immunosuppression mechanism. Microrna. 2:194–204
58. Fabbri, M., A., Paone, F., Calore, et al. 2012. MicroRNAs bind to toll-like receptors to induce prometastatic inflammatory response. Proc. Natl. Acad. Sci. USA. 109:E2110–E2116
59. Buzas, E. I., B., Gyorgy, G., Nagy, et al. 2014. Emerging role of extracellular vesicles in inflammatory diseases. Nat. Rev. Rheumatol. 10:356–364
60. Skriner, K., K., Adolph, P. R., Jungblut, et al. 2006. Association of citrullinated proteins with synovial exosomes. Arthritis Rheum. 54:3809–3814
61. Kapsogeorgou, E. K., R. F., Abu-Helu, H. M., Moutsopoulos, et al. 2005. Salivary gland epithelial cell exosomes:a source of autoantigenic ribonucleoproteins. Arthritis Rheum. 52:1517–1521
62. Rahman, M. J., D., Regn, R., Bashratyan, et al. 2014. Exosomes released by islet-derived mesenchymal stem cells trigger autoimmune responses in NOD mice. Diabetes. 63:1008–1020
63. Martinez-Lostao, L., F., Garcia-Alvarez, G., Basanez, et al. 2010. Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis. Arthritis Rheum. 62:2272–2282
64. Martinez-Lorenzo, M. J., A., Anel, B., Saez-Gutierrez, et al. 2007. Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL. Clin. Immunol. 122:28–40
65. Mohan, C., and S., Assassi. 2015. Biomarkers in rheumatic diseases:how can they facilitate diagnosis and assessment of disease activity? BMJ. 351:h5079
66. Park, J. Y., J. E., Lee, J. B., Park, et al. 2014. Roles of long non-coding RNAs on tumorigenesis and glioma development. Brain. Tumor. Res. Treat. 2:1–6
67. Qiu, M. T., J. W., Hu, R., Yin, et al. 2013. Long noncoding RNA:an emerging paradigm of cancer research. Tumour Biol. 34:613–620
68. Hung, T., and H. Y., Chang. 2010. Long noncoding RNA in genome regulation:prospects and mechanisms. RNA Biol. 7:582–585
69. Shi, X., M., Sun, H., Liu, et al. 2013. Long non-coding RNAs:a new frontier in the study of human diseases. Cancer Lett. 339:159–166
70. Wang, J., Y., Zhou, J., Lu, et al. 2014. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma. Med. Oncol. 31:148–155
71. Song, J., D., Kim, J., Han, et al. 2015. PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis. Clin. Exp. Med. 15:121–126
72. Yang, C., and P. D., Robbins. 2012. Immunosuppressive exosomes:a new approach for treating arthritis. Int. J. Rheumatol. 2012:573528
73. Cai, Z., W., Zhang, F., Yang, et al. 2012. Immunosuppressive exosomes from TGF-beta1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells. Cell. Res. 22:607–610
74. Kim, S. H., E. R., Lechman, N., Bianco, et al. 2005. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J. Immunol. 174:6440–6448
75. Kim, S. H., N. R., Bianco, W. J., Shufesky, et al. 2007. Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4. J. Immunol. 179:2242–2249
76. Kim, S. H., N., Bianco, R., Menon, et al. 2006. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Mol. Ther. 13:289–300
77. Bianco, N. R., S. H., Kim, A. E., Morelli, et al. 2007. Modulation of the immune response using dendritic cell-derived exosomes. Methods. Mol. Biol. 380:443–455
78. Sabapatha, A., C., Gercel-Taylor, and D. D., Taylor. 2006. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am. J. Reprod. Immunol. 56:345–355
79. Hedlund, M., A. C., Stenqvist, O., Nagaeva, et al. 2009. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression:evidence for immunosuppressive function. J. Immunol. 183:340–351
80. Ostman, S., M., Taube, and E., Telemo. 2005. Tolerosome-induced oral tolerance is MHC dependent. Immunology. 116:464–476
81. Prado, N., E. G., Marazuela, E., Segura, et al. 2008. Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction. J. Immunol. 181:1519–1525
82. Admyre, C., S. M., Johansson, K. R., Qazi, et al. 2007. Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 179:1969–1978
83. Routsias, J. G., and A. G., Tzioufas. 2010. Autoimmune response and target autoantigens in Sjogren's syndrome. Eur. J. Clin. Invest. 40:1026–1036
84. Properzi, F., M., Logozzi, and S., Fais. 2013. Exosomes:the future of biomarkers in medicine. Biomark Med. 7:769–778
85. Michael, A., S. D., Bajracharya, P. S. T., Yuen, et al. 2010. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 16:34–38
86. Palanisamy, V., S., Sharma, A., Deshpande, et al. 2010. Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS One. 5:e8577
87. Zan, H., C., Tat, and P., Casali. 2014. MicroRNAs in lupus. Autoimmunity. 47:272–285
88. Pisetsky, D. S., 2014. The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE. Autoimmunity. 47:487–493
89. Ortega, L. M., D. R., Schultz, O., Lenz, et al. 2010. Review:lupus nephritis:pathologic features, epidemiology and a guide to therapeutic decisions. Lupus. 19:557–574
90. Pisitkun, T., R. F., Shen, and M. A., Knepper. 2004. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad Sci. USA. 101:13368–13373
91. Miranda, K. C., D. T., Bond, M., McKee, et al. 2010. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 78:191–199
92. Zhou, H., A., Cheruvanky, X., Hu, et al. 2008. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int. 74:613–621
93. Barutta, F., M., Tricarico, A., Corbelli, et al. 2013. Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS One. 8:e73798
94. Bala, S., J., Petrasek, S., Mundkur, et al. 2012. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology. 56:1946–1957
95. Perez-Hernandez, J., M. J., Forner, C., Pinto, et al. 2015. Increased urinary exosomal microRNAs in patients with systemic lupus erythematosus. PLoS One. 10:e0138618
96. Wang, G., L. S., Tam, E. K., Li, et al. 2011. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus. 20:493–500
97. Sole, C., J., Cortes-Hernandez, M. L., Felip, et al. 2015. miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. Nephrol. Dial. Transplant. 30:1488–1496
98. Ichii, O., S., Otsuka-Kanazawa, T., Horino, et al. 2014. Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis. PLoS One. 9:e110383
99. Thery, C., M., Ostrowski, and E., Segura. 2009. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9:581–593
100. Yanez-Mo, M., P. R., Siljander, Z., Andreu, et al. 2015. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles. 4:27066–27125
101. Alvarez-Erviti, L., Y., Seow, H., Yin, et al. 2011. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29:341–345
102. van Dommelen, S. M., P., Vader, S., Lakhal, et al. 2012. Microvesicles and exosomes:opportunities for cell-derived membrane vesicles in drug delivery. J. Control Release. 161:635–644